|
1. An oral liquid formulation, comprising: (a) a combination of drugs wherein the drugs are selected from the group consisting of ezetimibe, statins, fenofibrate, amlodipine, valsartan, candesartan, telmisartan, losartan and salts thereof; (b) about 20% to about 90% w/w of one or more non-ionic surfactants that are liquids at ambient conditions; (c) about 0.05% to about 7.5% w/w of a co-solvent selected from the group consisting of an oil, glycerin, propylene glycol, polyethylene glycols that are liquids at ambient conditions, C1-C6 straight and branch monoalcohols and combinations thereof; (d) about 0.1% to about 5% w/w of a buffering agent, and (e) water wherein if present the ezetimibe is present in an amount of 0.05% to 10% w/w and if present the statins, fenofibrate, amlodipine, valsartan, candesartan, telmisartan, losartan and salts thereof are present in an amount of 0.05% to 20% w/w.
|